HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.

AuthorsP J Preidecker, K C Agrawal, A C Sartorelli, E C Moore
JournalMolecular pharmacology (Mol Pharmacol) Vol. 18 Issue 3 Pg. 507-12 (Nov 1980) ISSN: 0026-895X [Print] United States
PMID7007866 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Cytosine Nucleotides
  • Iron Chelating Agents
  • Isoquinolines
  • Thiosemicarbazones
  • 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone
  • Cytidine Diphosphate
  • Ribonucleotide Reductases
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Cytidine Diphosphate (metabolism)
  • Cytosine Nucleotides (metabolism)
  • Escherichia coli (enzymology)
  • Iron Chelating Agents (pharmacology)
  • Isoquinolines (pharmacology)
  • Kinetics
  • Liver Neoplasms, Experimental (metabolism)
  • Oxidation-Reduction
  • Ribonucleotide Reductases (metabolism)
  • Thiosemicarbazones (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: